Description
BSE announces upcoming listing of Gujarat Kidney and Super Speciality Limited equity shares with scrip code 544666 and symbol GKSL.
Summary
BSE has announced that the equity shares of Gujarat Kidney and Super Speciality Limited will be listed and admitted to dealings on the Exchange in due course. The company has been assigned scrip code 544666, trading symbol GKSL, and ISIN number INE0V0W01025. The exact listing date and security details will be communicated through a separate notice.
Key Points
- Company Name: Gujarat Kidney and Super Speciality Limited
- Scrip Code: 544666
- Trading Symbol: GKSL
- ISIN Number: INE0V0W01025
- Listing will occur on BSE in due course
- Specific listing date to be announced separately
Regulatory Changes
No regulatory changes. This is a standard listing announcement.
Compliance Requirements
Trading members of the Exchange are informed about the upcoming listing. No specific compliance actions required at this time. Members should await the subsequent notice with listing date and security details.
Important Dates
- Notice Date: December 29, 2025
- Listing Date: To be announced through separate notice
Impact Assessment
This announcement has limited immediate market impact as it is a preliminary notification. The listing will add a new healthcare sector company (kidney and super-specialty services) to BSE’s equity segment. Specific impact on trading activity will depend on the company’s offering size and investor interest, details of which will be provided in the forthcoming listing notice.
Impact Justification
Standard new listing announcement with medium importance for investors tracking IPOs/new listings, but low market-wide impact as specific listing date not yet announced